ME1 and colorectal carcinoma: The body of work implicating fatty acid synthesis in CRC initiation, progression and metastasis12–14, coupled with the documented role of ME1 in promoting lipogenesis in gut epithelium via the NADPH supply9,19, further identifies this pathway as a vulnerability to exploit for CRC treatment and therapy.